Apoptosis Induced by Chemotherapy Associated with p53 Gene Status in Gastric Cancer

Research conducted at Gifu University in Japan suggests that the efficacy of certain chemotherapy treatments for gastric cancer may be linked to the status of the p53 gene. A study published in the International Journal of Oncology found that cancers with wild-type p53 may respond better to treatment with 5-fluorouracil (5-FU), cisplatin (CDDP), and 5-FU plus CDDP (FP) than those with mutant-type p53. Furthermore, the study indicates that paclitaxel, an anticancer drug that may act through a p53-independent pathway, could be a suitable alternative for patients with mutant-type p53.

Key Takeaways:

  • The p53 gene status may be a prognostic indicator for the effectiveness of 5-FU, CDDP, and FP treatment in gastric cancer patients, with wild-type p53 cancers being more responsive to treatment.
  • Cells with mutant-type p53 are suggested to be less responsive to FP chemotherapy treatment, indicating a potential need for alternative treatment options.
  • Paclitaxel, a p53-independent anticancer drug, may be a suitable alternative for patients with gastric cancer and mutant-type p53.
  • The study suggests that cells with mutant-type p53 may require a different treatment approach, such as second-line chemotherapy or adjuvant chemotherapy.
  • The insights from this study may provide a new strategy for gastric cancer chemotherapy, particularly for patients with mutant-type p53.

Statistics:

  • The study examined two human gastric cancer cell lines, MKN45 and MKN28, which were found to have mutant-type p53.
  • Paclitaxel arrested cells in the G2/M phases of the cell cycle after 24 h in both MKN45 and MKN28 cells.
  • The number of subG1-phase cells in both MKN45 and MKN28 cells increased significantly after 72 h of paclitaxel treatment, as measured by flow cytometry histogram.

Sources:

  • N. Matsuhashi et al., "Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines," International Journal of Oncology, 2005; 26(6):1563-1567.
  • Health & Medicine Week editors, "Apoptosis Induced by Chemotherapy Associated with p53 Gene Status in Gastric Cancer," Health & Medicine Week, 2005.
  • Gifu University, School of Medicine, Dept. Surgery Oncology, 1-1 Yanagido, Gifu 5011194, Japan.
  • International Journal of Oncology, Editorial Office, 1, S Merkouri St., Athens 116 35, Greece.